SHERVINGTON, LEROY - University of Central Lancashire - School of Pharmacy and Biomedical Sciences

个人简介

1980-1983 BSc Single Hons. Chemistry II.I. University College Cardiff 1983-1986 PhD (Medicinal Organic Chemistry). University College Cardiff. “Studies on a New Synthesis of Chromans”. 1992-1993 City and Guild 730 teaching qualification for Further Education, the D33 Assessors Award for GNVQ assessments. 1993-1994 Postgraduate Certificate in Education PGCE (Post Compulsory Education and Training) Kingston University, UK. 2004-2006 Postgraduate Certificate in Research Student Supervision PGCSS (UCLan). 2005-2006 University Certificate in Higher Education Teaching Toolkit (UCLan).

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zarine Khan, Leroy Shervington, Amal Shervington (2012) Is cd133 the appropriate stem cell marker for glioma? In: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 1 Series: Stem Cells and Cancer Stem Cells, Hayat, M.A. (Ed.) Volume 1, Part 3, 107-112. Mehta, A.; Shervington, L.; Munje, C.; Shervington, A. A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90a. Cancers 2011, 3, 4228-4244. Chinmay Munje, Leroy Shervington, Adi Mehta, Zarine Khan, Amal Shervington (2011) Validating the Efficacy of ShRNA Vs SiRNA In Silencing Hsp90α In Gliomas. Journal of Bioanalysis & Biomedicine (doi: 10.4172/1.S3-002). D.Thakkar, Leroy Shervington and Amal Shervington (2011) Proteomic studies coupled with RNA methodologies can shed further light on the downstream effects of telomerase in glioma, Cancer Investigation 29(2) 113-122.